<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01512992</url>
  </required_header>
  <id_info>
    <org_study_id>RH_pilotCAT</org_study_id>
    <secondary_id>EC Grant Agreement 250487</secondary_id>
    <nct_id>NCT01512992</nct_id>
  </id_info>
  <brief_title>Home Telehealth Follow-up After Hospital Discharge for Chronic Obstructive Pulmonary Disease (COPD) Patients</brief_title>
  <official_title>Renewing Health RCT in Catalonia for the Evaluation of Home Telehealth Follow-up After Hospital Discharge for COPD Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Catalan Agency for Health Information, Assessment and Quality</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fundació TicSalut</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Clinic of Barcelona</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital de Mataró</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Catalan Agency for Health Information, Assessment and Quality</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the effects of a complex telemedicine intervention as
      a part of an integrated care program for patients with chronic obstructive pulmonary disease
      (COPD) discharged from the hospital after disease exacerbation. Will be evaluated whether the
      intervention produces benefits in terms of mortality, reduction in hospital readmissions and
      health-related quality of life. In addition, the trial evaluates the economical and
      organizational impact of the new service and examines its acceptability by patients and
      health professionals.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>April 2012</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">October 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of hospital readmissions</measure>
    <time_frame>3 months period</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Health related quality of life of the patients as measured by the SF-36 v2 questionnaire</measure>
    <time_frame>3 months - at baseline and study end</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital anxiety and depression scale HADS</measure>
    <time_frame>3 months - at baseline and study end</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lung condition as measured by FEV1</measure>
    <time_frame>3 months - at baseline and study end</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Condition-related health status measured by COPD Assessment Test (CAT)</measure>
    <time_frame>3 months - at baseline and study end</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>3 months period</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patients' Acceptance-Satisfaction measured by the WSD Questionnaire</measure>
    <time_frame>at the 3rd month of the telehealth intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time in days to first readmission</measure>
    <time_frame>3 months period</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay in days for each readmission</measure>
    <time_frame>3 months period</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of emergency room visits</measure>
    <time_frame>at the 3rd month (end of trial)</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">380</enrollment>
  <condition>Pulmonary Disease, Chronic Obstructive</condition>
  <arm_group>
    <arm_group_label>Home telehealth</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Home telehealth</intervention_name>
    <description>Patients receive tailored intervention according to their clinical complexity.
All patients in the intervention group receive:
Personalised care plan
Education on self-management
Access to a personalized online health folder
Access to Call center
Access to primary care and hospital specialists; follow-up visits for evaluation of clinical recovery and care plan adjustments (if needed).
Patients with LOW complexity additionally receive:
Daily videoconferences for the 1st week after discharge
Remote monitoring for respiratory parameters. Sensors are selected on an individual basis by the medical specialists.
Patients with HIGH complexity additionally receive:
Videoconferences for at least 1 month after discharge, scheduled on an individual basis.
Remote monitoring for respiratory parameters.
One monthly phone call from the call centre to promote and assess patient self-management.</description>
    <arm_group_label>Home telehealth</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Exacerbation of COPD

          -  Age &gt; 40 years

          -  Capability to use the devices provided

          -  Willing to participate

        Exclusion Criteria:

        • Participation in a previous COPD home telehealth study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Josep Roca Torrent, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pulmonary Department - Hospital Clinic of Barcelona</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Germans Trias i Pujol</name>
      <address>
        <city>Badalona</city>
        <state>Catalonia</state>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Capio Hospital Universitari Sagrat Cor</name>
      <address>
        <city>Barcelona</city>
        <state>Catalonia</state>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Clinic de Barcelona</name>
      <address>
        <city>Barcelona</city>
        <state>Catalonia</state>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital del Mar</name>
      <address>
        <city>Barcelona</city>
        <state>Catalonia</state>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Plató</name>
      <address>
        <city>Barcelona</city>
        <state>Catalonia</state>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital de Mataró</name>
      <address>
        <city>Mataró</city>
        <state>Catalonia</state>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Parc Taulí</name>
      <address>
        <city>Sabadell</city>
        <state>Catalonia</state>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Consorci Sanitari de Terrassa</name>
      <address>
        <city>Terrassa</city>
        <state>Catalonia</state>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Casas A, Troosters T, Garcia-Aymerich J, Roca J, Hernández C, Alonso A, del Pozo F, de Toledo P, Antó JM, Rodríguez-Roisín R, Decramer M; members of the CHRONIC Project. Integrated care prevents hospitalisations for exacerbations in COPD patients. Eur Respir J. 2006 Jul;28(1):123-30. Epub 2006 Apr 12.</citation>
    <PMID>16611656</PMID>
  </reference>
  <reference>
    <citation>Finkelstein SM, Speedie SM, Potthoff S. Home telehealth improves clinical outcomes at lower cost for home healthcare. Telemed J E Health. 2006 Apr;12(2):128-36.</citation>
    <PMID>16620167</PMID>
  </reference>
  <reference>
    <citation>Polisena J, Tran K, Cimon K, Hutton B, McGill S, Palmer K, Scott RE. Home telehealth for chronic obstructive pulmonary disease: a systematic review and meta-analysis. J Telemed Telecare. 2010;16(3):120-7. doi: 10.1258/jtt.2009.090812. Epub 2010 Mar 2. Review.</citation>
    <PMID>20197355</PMID>
  </reference>
  <verification_date>September 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 16, 2012</study_first_submitted>
  <study_first_submitted_qc>January 19, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 20, 2012</study_first_posted>
  <last_update_submitted>September 4, 2013</last_update_submitted>
  <last_update_submitted_qc>September 4, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 5, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
    <mesh_term>Chronic Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

